Median Technologies to speak at the Radiological Society of North America (RSNA) 2022 Annual Meeting, Nov. 27 – Dec 1, Chicago, IL, USA, with three presentations

Sophia-Antipolis, France

Press release – For immediate release – 5:45 pm CET

Median Technologies to speak at the Radiological Society of North America (RSNA) 2022 Annual Meeting, Nov. 27 – Dec 1, Chicago, IL, USA, with three presentations

  • AI Showcase Theater Presentation: “Enabling Lung Cancer Screening with iBiopsy® AI-based Software as Medical Device”
  • Scientific Presentation: ”Development of an AI/ML Tech Based Pulmonary Nodule Malignancy Prediction Model: Application to Indeterminate Pulmonary Nodules and Early-Stage Cancers”
  • Virtual Poster Presentation: “Discordance rates on primary tumor assessment between Blinded Independent Central Review (BICR) readers in advanced or metastatic esophageal cancer applying RECIST 1.1 criteria”
  • Median’s teams will be at booth #4849 AI showcase, to present the latest developments on iBiopsy® as well as its imaging CRO offering.

Median Technologies (ALMDT) announced today that the Company will be speaking and presenting at the world’s largest medical imaging conference, the 2022 Radiological Society of North America (RSNA) Annual Meeting and Scientific Assembly, being held in Chicago, IL, USA, Nov. 27 – Dec. 1.

The Company will give an industry presentation and two scientific presentations. Details of the sessions include:

Industry presentation:Enabling lung cancer screening with iBiopsy® AI-based software as medical device

Session: AI Showcase Theater

Date: November 27, 2022

Time: 11:30 am – 11:45 am CST

Place: South Hall Level 3, AI showcase theater

Virtual Poster Presentation: “Discordance rates on primary tumor assessment between Blinded Independent Central Review (BICR) readers in advanced or metastatic esophageal cancer applying RECIST 1.1 criteria”

Session Number: W5B-SPGI

Date: November 30, 2022

Time: 12:45 pm – 1:15 pm CST

Place: East Level 3, Learning Center – GI DPS

Scientific Presentation: ”Development of an AI/ML Tech Based Pulmonary Nodule Malignancy Prediction Model: Application to Indeterminate Pulmonary Nodules and Early-Stage Cancers”

Session Number: W7-SSIN06-1

Date: November 30, 2022

Time: 3.00 pm – 4.00 pm CST

Place: South Level 4, S404

Median’s teams will be available at booth #4849, Level 3 South Hall (AI showcase) for the duration of the industry exhibition (Nov 27- 30).

Download 20221122_PR_RSNA_EN_final-.pdf